These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3976757)

  • 21. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
    Brancazio LR; Murtha AP; Heine RP
    N Engl J Med; 2003 Sep; 349(11):1087-8; author reply 1087-8. PubMed ID: 12968095
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
    Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
    Facchinetti F; Vergani P; Di Tommaso M; Marozio L; Acaia B; Vicini R; Pignatti L; Locatelli A; Spitaleri M; Benedetto C; Zaina B; DʼAmico R
    Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial.
    Briery CM; Klauser CK; Martin RW; Magann EF; Chauhan SP; Morrison JC
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1892-6. PubMed ID: 24512252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic use of hydroxyprogesterone caproate in abdominal surgery during pregnancy. A retrospective evaluation.
    Hill LM; Johnson CE; Lee RA
    Obstet Gynecol; 1975 Sep; 46(3):287-90. PubMed ID: 1161231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACOG Committee Opinion. Use of progesterone to reduce preterm birth.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2003 Nov; 102(5 Pt 1):1115-6. PubMed ID: 14672496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestogen administration in pregnancy may prevent preterm delivery.
    Keirse MJ
    Br J Obstet Gynaecol; 1990 Feb; 97(2):149-54. PubMed ID: 2138496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
    Reijnders FJ; Thomas CM; Doesburg WH; Rolland R; Eskes TK
    Br J Obstet Gynaecol; 1988 May; 95(5):462-8. PubMed ID: 3135831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo.
    Klebanoff MA; Meis PJ; Dombrowski MP; Zhao Y; Moawad AH; Northen A; Sibai BM; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Leveno KJ; Miodovnik M; Conway D; Wapner RJ; Carpenter M; Mercer BM; Ramin SM; Thorp JM; Peaceman AM;
    Am J Obstet Gynecol; 2008 Nov; 199(5):506.e1-7. PubMed ID: 18456237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
    Rozenberg P; Chauveaud A; Deruelle P; Capelle M; Winer N; Desbrière R; Perrotin F; Bohec C; Connan L; Vayssière C; Langer B; Mantel A; Azimi S; Porcher R; Azria E;
    Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.
    Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Thom EA; Spong CY; Varner M; Malone F; Iams JD; Mercer BM; Thorp J; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M; Anderson G;
    N Engl J Med; 2007 Aug; 357(5):454-61. PubMed ID: 17671253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention.
    Bandino JP; Thoppil J; Kennedy JS; Hivnor CM
    Cutis; 2011 Nov; 88(5):241-3. PubMed ID: 22272488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.
    Lim AC; Bloemenkamp KW; Boer K; Duvekot JJ; Erwich JJ; Hasaart TH; Hummel P; Mol BW; Offermans JP; van Oirschot CM; Santema JG; Scheepers HC; Schöls WA; Vandenbussche FP; Wouters MG; Bruinse HW;
    BMC Pregnancy Childbirth; 2007 Jun; 7():7. PubMed ID: 17578562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How HY; Barton JR; Istwan NB; Rhea DJ; Stanziano GJ
    Am J Obstet Gynecol; 2007 Sep; 197(3):260.e1-4. PubMed ID: 17826411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progesterone and 6-methyl-17-hydroxyprogesterone acetate in the treatment of threatened premature labor].
    CIULLA U
    Ann Ostet Ginecol; 1960 May; 82():537-45. PubMed ID: 13810388
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A; Cleary-Goldman J; Istwan NB; Rhea DJ; Desch C; Russo-Stieglitz K; Saltzman DH
    Am J Perinatol; 2008 May; 25(5):271-5. PubMed ID: 18401840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.